Jaeeun Kim is a Scientist in the Cell Line Development group at Samsung Biologics. She has successfully led and completed various CLD to IND filings, demonstrating expertise in product development and regulatory compliance. From 2023 to 2024, Jaeeun played a key role in establishing a transposase-based platform to enhance CLD capabilities. She brings extensive experience working with various molecular formats, including mAbs, bsAbs, and other next-generation biologics.